Arcus Biosciences Inc at Barclays Global Healthcare Conference Transcript
Good morning. My name is Peter Lawson. Welcome to Barclays Global Healthcare Conference in Miami. I'm really pleased to have with us -- up on the stage with us, Arcus. So we've got management team. We've got Terry Rosen, CEO, Co-Founder; and Jennifer Jarrett, COO.
Questions & Answers
And I guess the first question would be really around -- I guess you've answered this multiple times around ARC-7, kind of underperformance, kind of how you think about the -- your PD-1 versus other PD-1s. And I know this -- you've got some historical perspective as well around that and how those have changed over time.
Sure. So we don't think the anti-PD-1 is underperforming in any way. We think zimberelimab, looks just like KEYTRUDA, looks like the other anti-PD-1s and without spending a ton of time
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |